Safety study of BIIB145 in healthy adults
This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy, with no major medical conditions like heart disease or cancer.
- Your body mass index (BMI) is between 18 and 32, and you weigh more than 50 kilograms (about 110 pounds).
- You have no history of bleeding problems, blood clots, or abnormal bleeding.
- You have not received any vaccines in the last 30 days or plan to get one during the study.
- You have not taken any medications that target your immune system's lymphocytes (a type of white blood cell) in the past 3 months.
- You do not have any back problems, spinal surgery, or conditions that would make a spinal tap (lumbar puncture) risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
This trial tests the safety of a new drug called BIIB142 and how the body processes it. It is for healthy volunteers aged 18 to 55.
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
This trial tests the safety of a new oral drug, ABBV-1042, in healthy adults. It helps researchers understand how the drug moves through the body and what side effects may occur.
This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.